Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-02-01 to 2023-02-02
Current total value of award: $107.42
Description: 4559908313!DICLOFENAC-MISOPROST 50-0.2 MG 60S